News
Clinical Trials Arena on MSN3d
FDA clears OBI Pharma’s IND to begin Phase I/II solid tumour trialOBI Pharma has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback